Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Organon Llc Drug Patent Portfolio

Organon Llc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Organon Llc News

Novartis Stock Declines While Avidity Biosciences Rises After $12 Billion Acquisition Agreement

28 Oct, 2025

Reuters reports that there may be a potential connection between mental health issues and the previous popular asthma drug, Singulair, developed by Merck.

22 Nov, 2024

Organon expands its presence in the dermatology sector through the acquisition of Roivant's dermatology subsidiary

18 Sep, 2024

Organon to acquire Dermavant and its steroid-free skin cream Vtama for a sum up to $1.2B

18 Sep, 2024

See More